Clinical Trial Update: Tipifarnib in Treating Patients With Recurrent Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tipifarnib for recurrent bladder cancer has completed (status: COMPLETED) according to the sponsor University Health Network…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED